… For this reason we did not count in the primary analysis participant’s transferred to another
clinic as retained as it could result in a overestimate of the patients retained in care at one …

… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …

… In the present study the Cronbach’s α coiffecient was used as an estimate of the test
reliability. The range between 0.70 and 0.90 is considered as the minimum required value. …

We evaluated rates and determinants of virological failure in triple-class experienced patients
receiving raltegravir-based regimens from a national observational study over 48 weeks, …

Background: In Ethiopia data concerning the influence of gender on death associated with
HIV/AIDS and loss to follow-up in care and treatment are controversial. Objective: Our study …

Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir
and /or maraviroc: 96 weeks data from the ISS NIA cohort study IRIS IRIS Home Sfoglia …

A modified Chromium 10x droplet-based protocol that subsamples cells for both short-read
and long-read (nanopore) sequencing together with a new computational pipeline (FLAMES) …

Background In about half of all patients with a suspected monogenic disease, genomic
investigations fail to identify the diagnosis. A contributing factor is the difficulty with repetitive …

JAHEE, Joint Action Health Equity Europe, is a project funded by the European Commission
and coordinated by the Istituto Superiore di Sanita (24 participating European countries; …

(CASA: un progetto di ricerca operazionale per migliorare la qualità della cura delle
persone con infezione da HIV in Ethiopia)-Nel 2012, secondo le stime dell’Organizzazione …